We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Shield Therapeutics Plc | LSE:STX | London | Ordinary Share | GB00BYV81293 | ORD 1.5P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
-0.10 | -3.39% | 2.85 | 2.80 | 2.90 | 2.95 | 2.85 | 2.90 | 2,684,036 | 08:23:30 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Pharmaceutical Preparations | 13.09M | -33.29M | -0.0429 | -0.66 | 22.88M |
Date | Subject | Author | Discuss |
---|---|---|---|
24/10/2024 08:03 | Yes please do share your wisdom Parot, I’m truly intrigued you clown | paul planet earth 1 | |
24/10/2024 07:56 | How does that work exactly? Please explain your logic you very intelligent person who likes to explain things | zeus19 | |
24/10/2024 07:44 | As mentioned yesterday, the harder PATT ramps this, the more it's likely to drop imo. Check out his history with ENET (he went all in) and be very careful. He is the laughing stock over there. | parob | |
24/10/2024 07:34 | Suits me. I said I was buying tomorrow and it looks like at sub 4p. Won’t change the Q3 figures but will get many more shares. | purchaseatthetop | |
24/10/2024 07:29 | Back into the 3's FFS | r9505571 | |
24/10/2024 07:29 | Nice to see new idiots arriving. Meanwhile it is a matter of seeing what the Q3 figures are like. | purchaseatthetop | |
24/10/2024 07:24 | I repeat be very careful if PATT turns up. His record is abysmal yet his arrogance is through the roof.DYOR. | parob | |
24/10/2024 05:36 | Thanks. Very pretty chart. Now above £100k every month. | purchaseatthetop | |
24/10/2024 04:22 | August NHS prescription numbers have been released hxxps://www.openpres | paul planet earth 1 | |
23/10/2024 21:29 | Plenty of lunatics? Our resident Ambulance driver has spoken or has he quit that job? | antonagis | |
23/10/2024 19:29 | And there are plenty of lunatics. | purchaseatthetop | |
23/10/2024 19:08 | In PURCHASEATTHETOP (Richard Bobath) we trust. www.mirror.co.uk/new | antonagis | |
23/10/2024 19:05 | Coming from a convicted criminal that’s a rich comment from PURCHASEATTHETOP | antonagis | |
23/10/2024 19:03 | RAZOBLADE Another blind disciple. Oh dear. He’ll certainly need a RAZORBLADE here. | antonagis | |
23/10/2024 17:31 | I've started blocking the guys who are following PATT wherever he goes, these guys may even follow him to the grave :) | razoblade | |
23/10/2024 16:01 | Always best to filter Dplewis. Then he doesn’t exist. | purchaseatthetop | |
23/10/2024 15:58 | Always uplifting to read your carping posts dplewis and you are wrong | photon | |
23/10/2024 15:58 | Hpcg. We might also get an update in the Q3 figures on the revenue treatment of the $5.7m China milestone payment. Is it balance sheet only or revenue? That would certainly help with covenants. | purchaseatthetop | |
23/10/2024 15:50 | No such thing as "need shares" or any other MM codes. Small caps are notorious for leaks and combined with the fact an active fraudster turned up ramping this recently I'd be a bit concerned | dplewis1 | |
23/10/2024 15:50 | This is just normal volatility. It looks like someone was eager to sell £80ks worth, which could be budget related, or just because they want less or no exposure going into the trading update. An insider trade would be hitting the offer a lot harder IMO, and noting that there are buyers on the other side. Value traded today £168k which is more than the past few days but less than 14 October. It's a Schrodinger's share price at the moment until we get the Q3 trading update, or at least prescription counts. | hpcg | |
23/10/2024 15:42 | Market has been posting 'need shares' trade codes for several days. Suspect they are just fishing for stock - and getting it as some holders are nervous based on past events! We await numbers and news.. then we can have a proper discussion. Hopefully by this time next week. | photon |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions